A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
- Status
- COMPLETED
- Phase
- PHASE4
Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS
- Status
- WITHDRAWN
- Phase
- PHASE3
Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation
- Status
- COMPLETED
- Phase
- PHASE2
Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool.
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.
- Status
- COMPLETED
- Phase
- PHASE3
An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis
- Status
- COMPLETED
- Phase
- PHASE4
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
- Status
- COMPLETED
- Phase
- PHASE4
Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
- Status
- COMPLETED
- Phase
- PHASE1
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.
- Status
- TERMINATED
- Phase
- PHASE2
An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)
- Status
- COMPLETED
- Phase
- PHASE4
A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
- Status
- COMPLETED
- Phase
- PHASE4